Evidence map›Paper›PMID 30134593›Full record

ArticleToxins2018

Steve Peigneur, Ana Luiza B Paiva, Marta N Cordeiro, Márcia H Borges, Marcelo R V Diniz, Maria Elena de Lima, Jan Tytgat

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. De Novo Transcriptome Analysis of the Venom ofMolecules (Basel, Switzerland) · 2021
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Steve PeigneurToxicology and Pharmacology, University of Leuven (KU Leuven), Campus Gasthuisberg, P.O. Box 922, Herestraat 49, 3000 Leuven, Belgium. steve.peigneur@kuleuven.be.ORCID 0000-0003-0504-5702
Ana Luiza B PaivaDepartamento de Pesquisa e Desenvolvimento, Fundação Ezequiel Dias, Minas Gerais, Belo Horizonte 30510-010, Brazil. analubpaiva@gmail.com.
Marta N CordeiroDepartamento de Pesquisa e Desenvolvimento, Fundação Ezequiel Dias, Minas Gerais, Belo Horizonte 30510-010, Brazil. martadonascimento.phoneutria@gmail.com.
Márcia H BorgesDepartamento de Pesquisa e Desenvolvimento, Fundação Ezequiel Dias, Minas Gerais, Belo Horizonte 30510-010, Brazil. mhborgesb@gmail.com.
Marcelo R V DinizDepartamento de Pesquisa e Desenvolvimento, Fundação Ezequiel Dias, Minas Gerais, Belo Horizonte 30510-010, Brazil. mdiniz@funed.mg.gov.br.
Maria Elena de LimaLaboratório de Venenos e Toxinas Animais, Dept de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 31270-901, Brazil. mariaelena@santacasabh.org.br.
Jan TytgatToxicology and Pharmacology, University of Leuven (KU Leuven), Campus Gasthuisberg, P.O. Box 922, Herestraat 49, 3000 Leuven, Belgium. stevepeigneur@gmail.com.
Ezequiel Dias Foundation · BRUniversidade Federal de Minas Gerais · BRKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spider venoms are complex mixtures of biologically active components with potentially interesting applications for drug discovery or for agricultural purposes. The spider

Indexed as

AnimalsFemaleInsectaIon Channel GatingMaleNeuropeptidesNeurotoxinsOocytesProtein IsoformsSodium ChannelsSpidersSpider VenomsXenopus laevisNeuropeptidesNeurotoxinsProtein IsoformsSodium ChannelsSpider VenomsTx2 neurotoxingating modifier toxininsecticidepeptide toxin PnTx2-1Phoneutria nigriventerspidervoltage-gated sodium channel

Identifiers

PMID30134593
PMCPMC6162791
OpenAlexW2888429218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.